To ask the Secretary of State for Wales if he will make a statement concerning the use in Wales for patients undergoing chemotherapy treatment, of the drug Kytril to combat nausea.

Kytril became commercially available from January this year after being licensed for use in December 1991. Any new drug is considered by the appropriate local drugs and therapeutic committee prior to its approval for either general or limited use. The use of Kytril is a matter for health authorities, as purchasers of health services for their residents, to consider.